Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology.
Major advances in early detection and therapy have significantly increased the survival of breast cancer patients. Unfortunately, most cancer therapies are known to carry a substantial risk of adverse long-term treatment-related effects. Little is known about patient susceptibility to severe side ef...
Main Authors: | Emily I Chen, Katherine D Crew, Meghna Trivedi, Danielle Awad, Mathew Maurer, Kevin Kalinsky, Antonius Koller, Purvi Patel, Jenny Kim Kim, Dawn L Hershman |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4692419?pdf=render |
Similar Items
-
A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
by: Eun Hee Sohn, et al.
Published: (2021-04-01) -
The Impact of SBF2 on Taxane-Induced Peripheral Neuropathy
by: Cunningham, Geneva Mari
Published: (2021) -
Taxanes induced peripheral neuropathy: mechanism of development and pharmacogenetic factors
by: L V Shestakova, et al.
Published: (2018-03-01) -
Melatonin, a Promising Role in Taxane-Related Neuropathy
by: Z. Nahleh, et al.
Published: (2010-01-01) -
Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
by: Alex Molassiotis, et al.
Published: (2019-06-01)